EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Digital pathology in tau research: A comparison of QuPath and HALO

Angelique D Gonzalez iD, Yannick N Wadop, Benjamin Danner, Kyra M Clarke iD, Matthew B Dopler, Ali Ghaseminejad-Bandpey, Sahana Babu, Julie Parker-Garza, Cole Corbett iD, Mohammad Alhneif, Mallory Keating, Kevin F Bieniek und 5 weitere

Journal of Neuropathology & Experimental Neurology · 01.08.2025 · 84 (8) · 692-706

DOI: 10.1093/jnen/nlaf026 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Neuropathology & Experimental Neurology, online erschienen am 16.04.2025. Verfasst von Angelique D Gonzalez und 16 weiteren Autor:innen. Beteiligte Einrichtung: Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, Unit…. Hauptthemen laut MEDLINE: Tauopathies, tau Proteins, Brain, Image Processing, Computer-Assisted. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, Neuropathology Core Leader, Baptist Foundation of San Antonio Endowment.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The application of digital pathology tools has expanded in recent years, but non-neoplastic human brain tissue presents unique challenges due to its complexity. This study evaluated HALO and QuPath tau quantification performance in the hippocampus and mid-frontal gyrus across various tauopathies. Percent positivity emerged as the most reliable measure, showing strong correlations with Braak stages and CERAD scores, outperforming object and optical densities. QuPath demonstrated superior correlations with Braak stages, while HALO excelled in aligning with CERAD scoring. However, HALO’s optical density was less consistent. Paired t-tests revealed significant differences in object and optical densities between platforms, though percent positivity was consistent across both. QuPath’s threshold-based object density showed similar agreement with manual counts compared to HALO’s AI-dependent approach (all ρ > 0.70). Reanalysis of QuPath further improved its agreement with manual measurements and correlations with Braak and CERAD scores (all ρ > 0.70). HALO offers a user-friendly interface and excels in certain metrics but is hindered by frequent software malfunctions and more limited flexibility. In contrast, QuPath’s customizable workflows and superior performance in Braak staging make it more suitable for advanced and larger-scale analyses. Overall, our study highlights the strengths and limitations of these platforms, helping guide their application in neuropathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tauopathiestau ProteinsBrainImage Processing, Computer-AssistedHumansMaleFemaleAgedAged, 80 and overMiddle Aged

Stichwörter der Autor:innen

AIHALOQuPathdigital pathologyquantitative image analysistautauopathy

Substanzen

tau Proteins

Autor:innen und Institutionen

  • Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, United States.
  • Department of Pathology and Laboratory Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, United States.
  • Institute of Neurosciences, School of Medicine, University of Texas Rio Grande Valley, Harlingen, TX, United States.
  • Rio Grande Valley Alzheimer's Disease Resource Center for Minority Aging Research (RGV AD-RCMAR), University of Texas Rio Grande Valley, Brownsville, TX, United States.
  • Department of Human Genetics, School of Medicine, University of Texas Rio Grande Valley, Brownsville, TX, United States.

ORCID-Profile: Angelique D Gonzalez, Kyra M Clarke, Cole Corbett, Shahroo Etemadmoghadam, Margaret E Flanagan

Förderung

  • NIA NIH HHS
  • Neuropathology Core Leader
  • Baptist Foundation of San Antonio Endowment
  • NINDS NIH HHS
  • Owen's Foundation
  • NIGMS NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Gonzalez, A. D., Wadop, Y. N., Danner, B., Clarke, K. M., Dopler, M. B., Ghaseminejad-Bandpey, A., Babu, S., Parker-Garza, J., Corbett, C., Alhneif, M., Keating, M., Bieniek, K. F., Maestre, G. E., Seshadri, S., Etemadmoghadam, S., Fongang, B., & Flanagan, M. E. (2025). Digital pathology in tau research: A comparison of QuPath and HALO. Journal of Neuropathology & Experimental Neurology, 84(8), 692-706. https://doi.org/10.1093/jnen/nlaf026

Vancouver

Gonzalez AD, Wadop YN, Danner B, Clarke KM, Dopler MB, Ghaseminejad-Bandpey A, et al. Digital pathology in tau research: A comparison of QuPath and HALO. Journal of Neuropathology & Experimental Neurology. 2025;84(8):692-706. doi:10.1093/jnen/nlaf026

BibTeX
@article{Gonzalez2025,
  author = {Gonzalez, Angelique D and Wadop, Yannick N and Danner, Benjamin and Clarke, Kyra M and Dopler, Matthew B and Ghaseminejad-Bandpey, Ali and Babu, Sahana and Parker-Garza, Julie and Corbett, Cole and Alhneif, Mohammad and Keating, Mallory and Bieniek, Kevin F and Maestre, Gladys E and Seshadri, Sudha and Etemadmoghadam, Shahroo and Fongang, Bernard and Flanagan, Margaret E},
  title = {Digital pathology in tau research: A comparison of QuPath and HALO},
  journal = {Journal of Neuropathology & Experimental Neurology},
  year = {2025},
  volume = {84},
  number = {8},
  pages = {692--706},
  doi = {10.1093/jnen/nlaf026}
}
Kostenlos starten →